Dynamic contrast-enhanced MDCT of the liver: Analysis of the effect of different iodine concentrations with the same total iodine dose in the same chronic liver disease patients

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 23, Issue 8, 2005, Pages 533-538

  Tozaki, Mitsuhiro ^a   Naruo, Kouichirou ^a   Fukuda, Kunihiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood supply; Contrast media; Dynamic computed tomography; Liver; Multidetector row computed tomography

Indexed keywords

CONTRAST MEDIUM; IODINE; IOPAMIDOL;

ABDOMINAL AORTA; ADULT; AGED; AORTA; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CONCENTRATION RESPONSE; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; HEPATIC ARTERY; HUMAN; LIVER BLOOD FLOW; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PORTAL VEIN; RADIATION ATTENUATION; SPLENIC VEIN; SYRINGE; TUMOR VASCULARIZATION;

AGED; AGED, 80 AND OVER; AORTA, ABDOMINAL; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; HEPATIC ARTERY; HUMANS; IODINE; IOPAMIDOL; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 31444446397     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hollett MD, Jeffrey RB Jr, Nino-Murcia M, et al. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms. AJR Am J Roentgenol, 164: 879-884, 1995.
2. Oliver JH 3rd, Baron RL, Federle MP, et al. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR Am J Roentgenol, 167: 71-77, 1996.
3. Mitsuzaki K, Yamashita Y, Ogata I, et al. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing. AJR Am J Roentgenol, 167: 753-757, 1996.
4. Hwang GJ, Kim MJ, Yoo HS, et al. Nodular hepatocellular carcinomas: detection with arterial-, portal-, and delayed-phase images at spiral CT. Radiology, 202: 383-388, 1997.
5. Lee HM, Lu DS, Krasny RM, et al. Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT. AJR Am J Roentgenol, 169: 125-130, 1997.
6. Kim T, Murakami T, Hori M, et al. Small hypervascular hepatocellular carcinoma revealed by double arterial phase CT performed with single breath-hold scanning and automatic bolus tracking. AJR Am J Roentgenol, 178: 899-904, 2002.
7. Awai K, Takada K, Onishi H, et al. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT. Radiology, 224: 757-763, 2002.
8. Heiken JP, Brink JA, McClennan BL, et al. Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight on hepatic enhancement. Radiology, 195: 353-357, 1995.
9. Kormano M, Partanen K, Soimakallio S, et al. Dynamic contrast enhancement of the upper abdomen: effect of contrast medium and body weight. Invest Radiol, 18: 364-367, 1983.
10. Vignaux O, Legmann P, Coste J, et al. Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients. AJR Am J Roentgenol, 173: 1193-1197, 1999.
11. Hayashi M, Matsui O, Ueda K, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol, 172: 969-976, 1999.
12. Hayashi M, Matsui O, Ueda K, et al. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology, 225: 143-149, 2002.
13. Suzuki K, Hayashi N, Miyamoto Y, et al. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res, 56: 3004-3009, 1996.
14. Yamaguchi R, Yano H, Iemura A, et al. Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology, 28: 68-77, 1998.
15. Megibow AJ, Jacob G, Heiken JP, et al. Quantitative and qualitative evaluation of volume of low osmolality contrast medium needed for routine helical abdominal CT. AJR Am J Roentgenol, 176: 583-589, 2001.
16. Yamashita Y, Komohara Y, Takahashi M, et al. Abdominal helical CT: evaluation of optimal doses of intravenous contrast material-a prospective randomized study. Radiology, 216: 718-723, 2000.
17. Engeroff B, Kopka L, Harz C, et al. Impact of different iodine concentrations on abdominal enhancement in biphasic multislice helical CT (MS-CT). Rofo, 173: 938-941, 2001.
18. Frederick MG, McElaney BL, Singer A, et al. Timing of parenchymal enhancement on dual-phase dynamic helical CT of the liver: how long does the hepatic arterial phase predominate? AJR Am J Roentgenol, 166: 1305-1310, 1996.
19. Kopka L, Rodenwaldt J, Fischer U, et al. Dual-phase helical CT of the liver: effects of bolus tracking and different volumes of contrast material. Radiology, 201: 321-326, 1996.
20. Sandstede JJ, Tschammler A, Beer M, et al. Optimization of automatic bolus tracking for timing of the arterial phase of helical liver CT. Eur Radiol, 11: 1396-1400, 2001.